Statins (HMG-CoA reductase inhibitors), cholesterol and stroke

被引：1

作者：

Marta-Moreno, J ^{[1
]}

Echeandia, C ^{[1
]}

Oliveros-Cid, A ^{[1
]}

Figuerola, A ^{[1
]}

Mola, S ^{[1
]}

机构：

[1] Hosp Miguel Servet, Serv Neurol, E-50009 Zaragoza, Spain

来源：

REVISTA DE NEUROLOGIA | 1998年 / 27卷 / 159期

关键词：

cerebral ischemia; cholesterol; HMG-CoA reductase; stroke;

D O I：

10.33588/rn.27159.98262

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The HMG-CoA reductase inhibitors (known as statins) have been shown to reduce morbi-mortality of vascular origin, including transitory ischemic accidents and cerebral infarcts, in a large group of patients. The implications, both clinical and of costs, oblige us to consider analysis of the existing evidence and the answers to a number of questions arising in a field which has not yet received much attention from neurologists.

引用

页码：827 / 830

页数：4

共 50 条

[41] Current data with HMG-CoA reductase inhibitors (statins) for colorectal cancer prevention
Tyagi, Preeta
Chu, Edward
Nadler, Eric
Jain, Vinay K.
CLINICAL COLORECTAL CANCER, 2005, 5 (04) : 245 - 246
[42] Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleAre all Statins the Same?
Marc Evans
Alan Rees
Drug Safety, 2002, 25 : 649 - 663
[43] Effects of HMG-CoA reductase inhibitors on skeletal muscle - Are all statins the same?
Evans, M
Rees, A
DRUG SAFETY, 2002, 25 (09) : 649 - 663
[44] Hepatic HMG-CoA reductase: A cholesterol buffer
Ness, GC
FASEB JOURNAL, 2000, 14 (08): : A1370 - A1370
[45] Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors
Samizo, Shigeyoshi
Kaneko, Hiromasa
ACS OMEGA, 2023, 8 (30): : 27247 - 27255
[46] HMG-CoA reductase inhibitors improve acute ischemic stroke outcome
Moonis, M
Kane, K
Schwiderski, U
Sandage, BW
Fisher, M
STROKE, 2005, 36 (06) : 1298 - 1300
[47] HMG-CoA reductase inhibitors reduce stroke risk, total mortality
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (19) : 2152 - &
[48] Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors
Benoit Chauvin
Sylvain Drouot
Aurélie Barrail-Tran
Anne-Marie Taburet
Clinical Pharmacokinetics, 2013, 52 : 815 - 831
[49] HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention (vol 55, pg 1055, 2000)
Papa, F
Bocola, V
NEUROLOGY, 2000, 55 (12) : 1942 - 1942
[50] KNOWN EFFECTS OF TREATMENT WITH HMG-COA REDUCTASE INHIBITORS (CHOLESTEROL-SYNTHESIS INHIBITORS)
KNISEL, W
EGGSTEIN, M
INTERNIST, 1989, 30 (12): : 776 - 783

← 1 2 3 4 5 →